{
    "clinical_study": {
        "@rank": "32020", 
        "brief_summary": {
            "textblock": "RATIONALE: Diagnostic procedures that detect residual disease may predict disease relapse in\n      patients who have hairy cell leukemia.\n\n      PURPOSE: Diagnostic trial to determine the effectiveness of analyzing blood and bone marrow\n      to detect residual disease in patients who have previously treated hairy cell leukemia."
        }, 
        "brief_title": "Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia", 
        "completion_date": {
            "#text": "August 2001", 
            "@type": "Actual"
        }, 
        "condition": "Leukemia", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Hairy Cell", 
                "Neoplasm, Residual"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Compare the sensitivity of flow cytometry, immunohistochemistry, and\n      polymerase chain reaction in detecting minimal residual disease following therapy with\n      cladribine in patients with hairy cell leukemia.\n\n      OUTLINE: Blood and bone marrow samples are obtained from patients at time of bone marrow\n      biopsies to assess minimal residual disease using flow cytometry, immunohistochemistry, and\n      polymerase chain reaction. Patients are followed for 2 years or until disease relapse.\n\n      PROJECTED ACCRUAL: A total of 15 patients will be accrued for this study over 12-24 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Clinically documented hairy cell leukemia Active or in remission\n        Must have received prior cladribine and be undergoing bone marrow biopsies as follow up\n\n        PATIENT CHARACTERISTICS: Age: Over 18 Performance status: Not specified Life expectancy:\n        Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: See Disease\n        Characteristics No prior chemotherapy following prior cladribine Endocrine therapy: Not\n        specified Radiotherapy: Not specified Surgery: Not specified"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with a documented diagnosis of hairy cell leukemia who are undergoing routine\n        bone marrow boipsy/aspiration and peripheral blood collection."
            }
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 2, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00005619", 
            "org_study_id": "NU 97Z3", 
            "secondary_id": [
                "NU-97Z3", 
                "NCI-G00-1754"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "polymerase chain reaction", 
                "intervention_type": "Genetic"
            }, 
            {
                "intervention_name": "flow cytometry", 
                "intervention_type": "Other"
            }, 
            {
                "intervention_name": "immunohistochemistry staining method", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "progressive hairy cell leukemia, initial treatment", 
            "refractory hairy cell leukemia"
        ], 
        "lastchanged_date": "February 18, 2011", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/NU-97Z3"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611"
                }, 
                "name": "Robert H. Lurie Comprehensive Cancer Center, Northwestern University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Detection of Hairy Cell Leukemia Minimal Residual Disease: Detection by Flow Cytometry", 
        "overall_official": {
            "affiliation": "Robert H. Lurie Cancer Center", 
            "last_name": "Loann C. Peterson, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2001", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00005619"
        }, 
        "responsible_party": {
            "name_title": "LoAnn Peterson, MD", 
            "organization": "Northwestern University"
        }, 
        "source": "Northwestern University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Northwestern University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2000", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2011"
    }, 
    "geocoordinates": {
        "Robert H. Lurie Comprehensive Cancer Center, Northwestern University": "41.878 -87.63"
    }
}